Literature DB >> 12614746

New surgical treatment for superior limbic keratoconjunctivitis and its association with conjunctivochalasis.

Norihiko Yokoi1, Aoi Komuro, Kunio Maruyama, Masakatsu Tsuzuki, Seiya Miyajima, Shigeru Kinoshita.   

Abstract

PURPOSE: To introduce a new surgical procedure for treating superior limbic keratoconjunctivitis (SLK) and to suggest the association of SLK with conjunctivochalasis.
DESIGN: Interventional case series.
METHODS: Six eyes of five patients with long-standing severe ocular irritation unresponsive to treatment with topical steroid and artificial tears were operated on using our new procedure. This technique consists of four steps as follows: (1) Rose bengal (RB) staining is used to localize the abnormal conjunctival area; (2) an arc-like conjunctival incision is placed from the 2 to the 10 o'clock position adjacent and distal to the RB-stained area; (3) the conjunctiva is resected to form a crescent using the arc-like incision as the base; the size of the resection is determined by conjunctival redundancy after removal of the subconjunctival connective tissue; and (4) the crescent conjunctival opening is closed with interrupted sutures. In two eyes, the new surgical procedure was performed together with surgery for inferior bulbar conjunctivochalasis.
RESULTS: In all operated eyes, RB staining had disappeared by the end of the second postoperative week; recovery from symptoms and loss of inflammation were recorded by 1 month after treatment. In the case with the longest follow-up (14 months), there was cytologic evidence of goblet cell recovery at 3 months after the operation. In another, there was normalization of the nucleo/cytoplasmic ratio of conjunctival cells without the appearance of goblet cells.
CONCLUSIONS: Our treatment very effectively resolved symptoms associated with SLK, even in eyes unresponsive to conventional therapy with eye drops. Considering that we did not address the diseased part of the conjunctiva but rather the adjacent conjunctival redundancy, we propose that superior bulbar conjunctivochalasis is involved in the pathogenesis of SLK. Copyright 2003 by Elsevier Science Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614746     DOI: 10.1016/s0002-9394(02)01975-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

1.  The relationship between clinical signs and dry eye symptoms.

Authors:  H Pult; C Purslow; P J Murphy
Journal:  Eye (Lond)       Date:  2011-01-21       Impact factor: 3.775

2.  Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.

Authors:  Alejandro Rodriguez-Garcia; Yolanda Macias-Rodriguez; Jose M Gonzalez-Gonzalez
Journal:  Int Ophthalmol       Date:  2017-06-10       Impact factor: 2.031

3.  Clinical characteristics of conjunctivochalasis with or without aqueous tear deficiency.

Authors:  M A Di Pascuale; E M Espana; T Kawakita; S C G Tseng
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

4.  Liquid nitrogen cryotherapy for surface eye disease (an AOS thesis).

Authors:  Frederick Web Fraunfelder
Journal:  Trans Am Ophthalmol Soc       Date:  2008

5.  Recharacterization of superior limbic keratoconjunctivitis via a subdividing grading method in 236 Chinese patients.

Authors:  Chao Cheng; Minyi Zhu; Tianlan Lin; Ziyan Chen; Weiting Zeng; Kunke Li; Ran Xue; Fang Duan; Kaili Wu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-02-03       Impact factor: 3.117

6.  Extensive superior limbic keratoconjunctivitis in Graves' disease: case report and mini-review of the literature.

Authors:  Elias Chelala; Hala El Rami; Ali Dirani; Henry Fakhoury; Ali Fadlallah
Journal:  Clin Ophthalmol       Date:  2015-03-10

7.  Evaluation of the Effects of Conjunctivochalasis Excision on Tear Stability and Contrast Sensitivity.

Authors:  Weiqiang Qiu; Mingzhou Zhang; Ting Xu; Ziyuan Liu; Huibin Lv; Wei Wang; Xuemin Li
Journal:  Sci Rep       Date:  2016-11-28       Impact factor: 4.379

8.  Real-world assessment of diquafosol in dry eye patients with risk factors such as contact lens, meibomian gland dysfunction, and conjunctivochalasis: subgroup analysis from a prospective observational study.

Authors:  Masahiko Yamaguchi; Takeshi Nishijima; Jun Shimazaki; Etsuko Takamura; Norihiko Yokoi; Hitoshi Watanabe; Yuichi Ohashi
Journal:  Clin Ophthalmol       Date:  2015-12-01

9.  Clinical characteristics of patients with conjunctivochalasis.

Authors:  Ozlem Balci
Journal:  Clin Ophthalmol       Date:  2014-08-28

Review 10.  Trends in conjunctivochalasis research from 1986 to 2017: A bibliometric analysis.

Authors:  Yanqing Zhao; Li Huang; Minhong Xiang; Qingsong Li; Wanhong Miao; Zhengchi Lou
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.